NIAID creates HIV vaccine discovery branch

Jun 25, 2008

To accelerate the translation of basic discoveries about HIV into advances in vaccine design and evaluation, the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), has formed a new Vaccine Discovery Branch within the Vaccine Research Program in the Division of AIDS (DAIDS).

"There is broad scientific consensus that designing a safe and effective vaccine to prevent HIV infection will require enormous advances beyond present-day knowledge," says NIAID Director Anthony S. Fauci, M.D. "The NIAID Vaccine Discovery Branch will help remove fundamental obstacles to achieving this goal by focusing intensively on the development and sharing of new knowledge critical to vaccine development."

The new branch is dedicated to monitoring scientific developments in multiple fields related to HIV vaccine discovery, building more bridges between basic researchers and HIV vaccine designers, identifying gaps in knowledge pertinent to a preventive HIV vaccine and promoting research to fill those gaps.

"Cross-fertilization of HIV/AIDS research with the fields of genetics, structural biology, systems biology and others could open up new perspectives on how to overcome major obstacles to HIV vaccine design," says DAIDS Director Carl W. Dieffenbach, Ph.D. "The Vaccine Discovery Branch will be in an ideal position to spot these opportunities, promote the translation of new knowledge about HIV and foster fruitful research collaborations."

In addition, the new branch will

  • Monitor vaccine discovery efforts and related basic HIV research within NIH, nationally and internationally

  • Determine funding priorities for vaccine discovery research

  • Plan, develop, implement and evaluate extramural grants and contracts to support the conduct of fundamental virology and immunology research as it relates to the discovery of novel AIDS vaccine concepts

  • Foster the development and supply of necessary research reagents and other resources

    The Vaccine Discovery Branch also will have chief oversight of the Center for HIV/AIDS Vaccine Immunology (CHAVI), a consortium of universities and academic medical centers established by NIAID to solve major problems in HIV vaccine development and design. A multidisciplinary group of scientists from across DAIDS will continue to participate in overseeing CHAVI.

    Jorge Flores, M.D., deputy director of the Vaccine Research Program, will serve as acting chief of the new branch until a national search results in the selection of a new chief. Dr. Flores has been involved in the conduct and administration of vaccine research at NIH since 1979.

    Source: NIH/National Institute of Allergy and Infectious Diseases

    Explore further: Small changes in eGFR with TDF preexposure prophylaxis

    add to favorites email to friend print save as pdf
  • Related Stories

    The science of collaboration

    Aug 28, 2013

    It's a long, expensive, risky road to turn a scientific breakthrough into a treatment that can help patients. Fewer organizations are trying to tackle the challenges alone, says a new paper from MIT researchers published ...

    Recommended for you

    Small changes in eGFR with TDF preexposure prophylaxis

    Dec 23, 2014

    (HealthDay)—For HIV-1-uninfected members of serodiscordant couples, tenofovir disoproxil fumarate (TDF) used as preexposure prophylaxis (PrEP) is associated with a small decrease in estimated glomerular ...

    FDA to ease ban on blood donations by gay men

    Dec 23, 2014

    Federal officials have moved closer to overturning a decades-old ban on blood donations from gay and bisexual men, but activists say the proposed alternative would continue to stigmatize men who have sex ...

    Consumer group sues Aetna, alleges discrimination

    Dec 23, 2014

    A consumer advocacy group has filed a class-action lawsuit against Aetna Inc. saying a new policy violates the privacy of people with HIV and AIDS by requiring them to get their medications from its mail-order pharmacy.

    Cambodia orders probe into mass HIV infection

    Dec 18, 2014

    Cambodian Prime Minister Hun Sen on Thursday ordered a probe into an apparent mass HIV infection believed to have been spread by contaminated needles, as the number of suspected cases passed 100.

    User comments : 0

    Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

    Click here to reset your password.
    Sign in to get notified via email when new comments are made.